Does RISANKIZUMAB-RZAA Cause Visual impairment? 244 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Visual impairment have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
244
Reports of Visual impairment with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
0
Deaths
54
Hospitalizations
How Dangerous Is Visual impairment From RISANKIZUMAB-RZAA?
Of the 244 reports, 54 (22.1%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Visual impairment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 244 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Visual impairment?
INSULIN GLARGINE (5,793)
INSULIN LISPRO (4,654)
ADALIMUMAB (3,770)
DUPILUMAB (3,089)
ETANERCEPT (2,489)
FINGOLIMOD (2,147)
AFLIBERCEPT (1,836)
PREGABALIN (1,714)
METHOTREXATE (1,588)
TOFACITINIB (1,544)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Visual impairment Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA